-
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer
28 Mar 2024 11:00 GMT
… -BAFF tetravalent bispecific antibody, from Eli Lilly and Company.
Enhanced and expanded the Board …
Research and development license consideration liability
—
2,634
Total current liabilities …
-
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
27 Mar 2024 20:01 GMT
… result in recalls or product liability claims; unfavorable results from preclinical … owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates. Contact …
-
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
27 Mar 2024 10:54 GMT
… , a wholly owned subsidiary of Eli Lilly and Company (Lilly), in applying ARCUS nucleases … candidates; pending and potential product liability lawsuits and penalties against us …
-
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
27 Mar 2024 10:53 GMT
… , a wholly owned subsidiary of Eli Lilly and Company (Lilly), in applying ARCUS nucleases … candidates; pending and potential product liability lawsuits and penalties against us …
-
Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy
27 Mar 2024 01:49 GMT
… co-developed by Innovent and Eli Lilly and Company. Sintilimab is a type of … this site; and (b) no liability in the event that any …
-
Indiana AG Todd Rokita files lawsuit against drug companies, PBMs over inflated insulin prices
20 Mar 2024 12:12 GMT
… most prominent employers, drug manufacturer Eli Lilly and Company, was not included in the … it made no admission of liability, the company also acknowledged an …
-
Impact Shares YWCA Women’s Empowerment ETF (WOMN) Reaches $50M in Assets Under Management
21 Mar 2024 10:30 GMT
MILWAUKEE, March 21, 2024 (GLOBE NEWSWIRE) -- Tidal Investments LLC announces that Impact Shares, a leading provider of socially conscious ETFs, has achieved a significant milestone. The YWCA Women’s Empowerment Fund ($WOMN) has surpassed $50 million in …
-
Acute Agitation And Aggression Drugs Market Research Report By Type, By Application Global Forecast To 2028 Eli Lilly And Company, Pfizer, Ono Pharmaceutical, Otsuka Holdings, Glaxosmithkline,
12 Aug 2022 21:06 GMT
… and Aggression Drugs Market are Eli Lilly and Company, Pfizer, Ono Pharmaceutical, Otsuka Holdings … not accept any responsibility or liability for the accuracy, content, images …
-
Eli Lilly and Company (LLY) CEO Dave Ricks on Q2 2022 Results - Earnings Call Transcript
04 Aug 2022 22:42 GMT
Eli Lilly and Company (NYSE:LLY) Q2 2022 Earnings … you for joining us for Eli Lilly and Company's Q2 2022 earnings … patients. Remember that a liability or potential liability of genitimab is antidrug …
-
Global Peptide Therapeutics Market Report 2022-2026 Featuring Novartis International, Glaxosmithkline, Bristol Myers Squibb, Amgen, Eli Lilly And Co & Polypeptide Group
28 Jul 2022 11:07 GMT
… Myers Squibb Co., Amgen Inc., Eli Lilly and Company and PolyPeptide Group AG) are … .4 Amgen Inc.
6.5 Eli Lilly and Company
6.6 PolyPeptide Group AG … not accept any responsibility or liability for the accuracy, content, images …